Background
Porocarcinoma (PC) is a cutaneous malignancy that differentiates towards the sweat ducts and glands. Lack of histological diagnostic markers makes clinical and pathological diagnosis complex. Limited data available suggests incidence is increasing, however this remains to be established in national epidemiological studies.
Objectives
To report the incidence, treatment and survival of PC in England from 1/01/2013 to 31/12/2018 using national cancer registry data.
Methods
PC diagnoses in England during 2013-18 were identified from the National Disease Registration Service using morphology and behaviour codes. These were registered from routinely collected pathology reports and cancer outcomes and services datasets. 2013 European age standardised incidence rates (EASR), Kaplan Meier all-cause survival and log rank test were calculated.
Results
738 tumours, 396 in males and 342 in females, were diagnosed. The median age at diagnosis was 82 years old (interquartile range 74-88). The most frequently affected site were lower limbs (35.4%), followed by the face (16%). The majority of the cohort received surgical excision (72.9%). The Kaplan Meier all cause survival was 45.4% at 5 years, which was lower than in previous studies.
The EASR for the whole population was 0.25 [95% confidence interval (CI) 0.23–0.27] per 100,000 person-years (PY)]. PC incidence rates in the East of England [EASR of 0.54 (95% CI 0.47–0.63) per 100,000 PY] were three times higher than the South West [EASR of 0.14 (95% CI 0.10–0.19) per 100,000 PY] where the regional rates were the lowest.
Conclusions
This study showed that there is large variation in the EASR of PC across England. This may reflect differences in how PC is diagnosed and registered in different regions in England. These data support national assessment of the management of porocarcinoma, which will inform future studies and guideline development.